DVA:NYE-DaVita Inc. (USD)

EQUITY | Medical Care Facilities | New York Stock Exchange

Last Closing

USD 145.92

Change

-9.04 (-5.83)%

Market Cap

USD 12.45B

Volume

2.30M

Analyst Target

USD 97.80
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

DaVita Inc, formerly DaVita HealthCare Partners Inc operates kidney dialysis centers and provides related lab services in dialysis centers and in contracted hospitals across USA. It also operates other ancillary services and strategic initiatives.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-20 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

-5.08 (-1.58%)

USD 81.54B
THC Tenet Healthcare Corporation

-7.64 (-5.57%)

USD 13.36B
UHS Universal Health Services Inc

-4.14 (-2.25%)

USD 12.40B
EHC Encompass Health Corp

-2.36 (-2.36%)

USD 10.06B
CHE Chemed Corp

-3.86 (-0.70%)

USD 8.24B
CON Concentra Group Holdings Paren..

-0.45 (-1.92%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

-0.94 (-6.33%)

USD 2.59B
NHC National HealthCare Corporatio..

-2.67 (-2.77%)

USD 1.90B
AGL agilon health Inc

-0.10 (-2.76%)

USD 1.41B
AMN AMN Healthcare Services Inc

+1.74 (+6.73%)

USD 1.05B

ETFs Containing DVA

SANE 4.09 % 0.00 %

N/A

N/A
PTH Invesco DWA Healthcare Mo.. 3.52 % 0.60 %

-3.02 (-1.26%)

USD 0.13B
SAGP The Advisorsa Inner Circl.. 2.09 % 0.00 %

-0.38 (-1.26%)

USD 0.04B
XLVE:CA 1.78 % 0.00 %

N/A

N/A
RSPH Invesco S&P 500 Equal Wei.. 1.76 % 0.00 %

-0.12 (-1.26%)

USD 0.85B
IBHJ iShares Trust - iShares i.. 1.56 % 0.00 %

-0.08 (-1.26%)

USD 0.05B
RSPE Invesco Exchange-Traded F.. 0.63 % 0.00 %

-0.39 (-1.26%)

USD 0.02B
JPME JPMorgan Diversified Retu.. 0.45 % 0.24 %

-1.44 (-1.26%)

USD 0.41B
JPUS JPMorgan Diversified Retu.. 0.44 % 0.19 %

-1.25 (-1.26%)

USD 0.44B
JPLG:LSE JPM Global Equity Multi-F.. 0.34 % 0.00 %

-13.75 (-1.26%)

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
PHB Invesco Fundamental High .. 0.00 % 0.50 %

-0.02 (-1.26%)

N/A
LSAF LeaderSharesTM AlphaFacto.. 0.00 % 0.75 %

-0.95 (-1.26%)

USD 0.15B
BACK:LSE 0.00 % 0.00 %

N/A

N/A
SLIM 0.00 % 0.50 %

N/A

N/A
JPGL:LSE JPM Global Equity Multi-F.. 0.00 % 0.00 %

N/A

USD 0.19B
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B
AZTD Aztlan Global Stock Selec.. 0.00 % 0.00 %

-0.41 (-1.26%)

USD 0.03B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.43% 25% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.43% 25% F 18% F
Trailing 12 Months  
Capital Gain 18.76% 70% C- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.76% 65% D 71% C-
Trailing 5 Years  
Capital Gain 73.53% 89% A- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 73.53% 89% A- 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 14.58% 52% F 74% C
Dividend Return 14.58% 52% F 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 34.29% 65% D 30% F
Risk Adjusted Return 42.51% 65% D 56% F
Market Capitalization 12.45B 90% A- 87% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Care Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.10 47% 59%
Price/Book Ratio 103.97 11% 1%
Price / Cash Flow Ratio 6.23 48% 55%
Price/Free Cash Flow Ratio 8.74 57% 55%
Management Effectiveness  
Return on Equity 51.74% 83% 97%
Return on Invested Capital 19.05% 86% 85%
Return on Assets 7.15% 85% 87%
Debt to Equity Ratio 7,575.75% 11% 1%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.